$2.03
0.021%
Last update: Nov 4, 7:52 AM
Compugen Ltd (CGEN) Stock Price, Quote, News & History
CGENNASDAQ
Gilead Sciences Inc (NASDAQ: GILD) announced an agreement with Compugen Ltd (NASDAQ: CGEN) to license its pre-clinical antibody program against IL-18 binding...
You can purchase shares of Compugen (NASDAQ:CGEN) through any online brokerage.
Other companies in Compugen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Compugen has a consensus price target of $4.60.
The stock price for Compugen (NASDAQ: CGEN) is $2.03 last updated November 4, 2026 at 7:52 AM EST.
There are no upcoming dividends for Compugen.
Compugen does not have any upcoming earnings scheduled.
There is no upcoming split for Compugen.
Compugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field...
